| Antidote | Indication | Initial dose (adult)* | Initial dose (pediatric)* | Maintenance infusion | Notes |
|---|---|---|---|---|---|
|
Atropine |
Organophosphates Carbamates |
1–2 mg, doubled every 5 min |
0.02 mg/kg, doubled every 5 min |
10%–20% of the total loading dose per hour up to 2 mg∙h−1 (adults) |
Titrate to reversal of bronchorrhea, bronchospasm, and bradycardia. |
|
Calcium chloride |
β-blockers CCBs |
2000 mg 28 mEq Ca2+ 20 mL 100 mg/mL solution |
20 mg/kg 0.28 mEq Ca2+/kg 0.2 mL/kg 100 mg/mL solution |
20–40 mg∙kg−1∙h−1 0.28–0.56 mEq Ca2+∙kg−1∙h−1 0.2–0.4 mL∙kg−1∙h−1 100 mg/mL solution |
Titrate to blood pressure. Do not exceed serum ionized calcium concentration 1.5–2 times the upper limits of normal. Administer through central line, especially in children. |
|
Calcium gluconate |
β-blockers CCBs |
6000 mg 28 mEq Ca2+ 60 mL 100 mg/mL solution |
60 mg/kg 0.28 mEq/kg Ca2+ 0.6 mL/kg 100 mg/mL solution |
60–120 mg∙kg−1∙h−1 0.28–0.56 mEq Ca2+∙kg−1∙h−1 0.6–1.2 mL∙kg−1∙h−1 100 mg/mL solution |
Titrate to blood pressure. Do not exceed serum ionized calcium concentration 1.5–2 times the upper limits of normal. |
|
Digoxin immune Fab |
Digoxin |
Acute overdose: 1 vial for every 0.5 mg digoxin ingested Chronic poisoning: Use formula: dose in vials=serum digoxin concentration (ng/mL)×weight (kg)/100 Acute overdose, critically ill, ingested dose unknown: 10–20 vials |
Same as adult |
None |
1 vial contains 40 mg Fab. Lower doses may be equally effective. 4 |
|
Digoxin immune Fab |
Yellow oleander Bufo toad venom and other cardioactive steroids |
1200 mg (30 vials) |
Unknown |
None |
|
|
Glucagon |
β-blockers CCBs |
2–10 mg |
0.05–0.15 mg/kg |
1–15 mg∙h−1 (adult) |
Anticipate vomiting. |
|
Flumazenil |
Benzodiazepines |
0.2 mg, titrated up to 1 mg |
0.01 mg/kg |
None |
Many contraindications |
|
Hydroxocobalamin |
Cyanide |
5 g |
70 mg/kg |
Repeat doses may be necessary. |
Transient hypertension |
|
Insulin |
β-blockers CCBs |
1 Units/kg |
Same as adult |
1–10 Units∙kg−1∙h−1 |
Regular human insulin. Monitor for hypoglycemia, hypokalemia, volume overload. |
|
Intravenous lipid emulsion |
Local anesthetics |
less than 70 kg: 1.5 mL/kg greater than 70 kg: bolus 100 mL over 2–3 min |
Same as adult |
less than 70 kg 0.25 mL∙kg−1∙min−1 for up to 30 min greater than 70 kg: 200–250 mL over 15–20 min |
All studies use 20% lipid emulsion. |
|
Methylene blue |
CCBs Methemoglobinemia |
1–2 mg/kg, repeated every hour if needed |
Same as adult |
1 mg∙kg−1∙h−1 (for vasodilatory shock) |
Maximum 5–7 mg/kg |
|
Naloxone |
Opioids |
0.2–2 mg IV/IO/IM 2–4 mg intranasal Repeat every 2–3 min as needed |
0.1 mg/kg |
Two thirds of the waking dose per hour |
Titrate to reversal of respiratory depression and restoration of protective airway reflexes. |
|
Pralidoxime |
Organophosphates |
2 g IV infusion over 15–30 min (do not bolus) or 0.6 g IM up to 3 doses |
20–50 mg/kg |
1 g∙h−1 (adult) 10–20 mg∙kg−1∙h−1 (pediatric) |
|
|
Sodium bicarbonate† |
Sodium channel blockers Cocaine Local anesthetics |
50–150 mEq |
1–3 mEq/kg |
Prepare 150 mEq/L solution, infuse at 1–3 mL∙kg−1∙h−1 |
Watch for hypernatremia, alkalemia, hypokalemia, hypochloremia. |
|
Sodium nitrite |
Cyanide |
300 mg |
6 mg/kg |
None |
Watch for hypotension. |
|
Sodium thiosulfate |
Cyanide |
12.5 g |
250 mg/kg |
None |
β-blockers indicates β-adrenergic receptor antagonists; CCBs, calcium channel blockers; Fab, fragment antigen binding; ILE, intravenous lipid emulsion; IM, intramuscular; IO, intraosseous; and IV, intravenous.
*Unless otherwise stated, the route of administration should be intravenous or intraosseous. Maximum pediatric dose should not exceed adult dose. Most antidotes should be repeated frequently and titrated to achieve control of critical signs and symptoms. The ideal dose of most antidotes is not known and is often controversial. Large doses are sometimes required to overcome competitive inhibition of molecular targets such as adrenergic receptors and ion channels. Consult a medical or clinical toxicologist, regional poison center, or topic-specific reference for detailed dosing and administration instructions.
†Different sodium bicarbonate solutions are typically used for adults (1 mEq/mL) and children (0.5 mEq/mL). Both formulations are hypertonic.